Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.


The monitoring of DEA-controlled substances for suspicious orders is widely recognized. Companies have an obligation not only to implement a system for identifying unusual-sized, frequent, and patterned orders of DEA-controlled substances but also to apply similar measures to monitor other product categories (such as State Controlled, High Potential for Diversion, and Rx).
Eric Pearcy
Engagement Manager, IQVIA
Scott Hardy
Sr. Engagement Manager, IQVIA
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
Navigate the challenge of compliance, and its vital association with quality